OTCMKTS:PURE - Pure Bioscience Stock Price, Price Target & More

$0.75 +0.09 (+13.64 %)
(As of 04/26/2018 11:32 AM ET)
Previous Close$0.66
Today's Range$0.67 - $0.75
52-Week Range$0.55 - $1.36
Volume7,638 shs
Average Volume41,565 shs
Market Capitalization$44.92 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.35

About Pure Bioscience (OTCMKTS:PURE)

Pure Bioscience logoPURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PURE
CUSIPN/A
Phone619-596-8600

Debt

Debt-to-Equity RatioN/A
Current Ratio4.00%
Quick Ratio3.62%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.83 million
Price / Sales27.89
Cash FlowN/A
Price / CashN/A
Book Value$0.02 per share
Price / Book37.50

Profitability

EPS (Most Recent Fiscal Year)($0.10)
Net Income$-6,260,000.00
Net Margins-460.07%
Return on Equity-260.04%
Return on Assets-168.32%

Miscellaneous

Employees13
Outstanding Shares68,060,000

How to Become a New Pot Stock Millionaire

Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) posted its earnings results on Wednesday, March, 14th. The company reported ($0.03) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The company had revenue of $0.41 million for the quarter, compared to the consensus estimate of $1.25 million. Pure Bioscience had a negative return on equity of 260.04% and a negative net margin of 460.07%. View Pure Bioscience's Earnings History.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, June, 14th 2018. View Earnings Estimates for Pure Bioscience.

Who are some of Pure Bioscience's key competitors?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the folowing people:
  • Mr. David J. Pfanzelter, Chairman (Age 65)
  • Mr. Henry R. Lambert, CEO & Director (Age 67)
  • Mr. Mark Stuart Elliott, Principal Financial & Accounting Officer and VP of Fin. (Age 43)
  • Mr. Gary L. Primes, VP of Operations
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

Has Pure Bioscience been receiving favorable news coverage?

Headlines about PURE stock have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Pure Bioscience earned a media sentiment score of 0.11 on Accern's scale. They also gave news articles about the company an impact score of 47.48 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.75.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $44.92 million and generates $1.83 million in revenue each year. The company earns $-6,260,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Pure Bioscience employs 13 workers across the globe.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 1725 GILLESPIE WAY, EL CAJON CA, 92020. The company can be reached via phone at 619-596-8600.


MarketBeat Community Rating for Pure Bioscience (PURE)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  96
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pure Bioscience (OTCMKTS:PURE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/26/2016 forward)

Earnings

Pure Bioscience (OTCMKTS:PURE) Earnings History and Estimates Chart

Earnings by Quarter for Pure Bioscience (OTCMKTS:PURE)

Pure Bioscience (OTCMKTS:PURE) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181($0.02)($0.02)($0.02)
Q4 20181($0.02)($0.02)($0.02)

Pure Bioscience (OTCMKTS PURE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/14/2018        
3/14/2018Q2 2018($0.02)($0.03)$1.25 million$0.41 millionViewN/AView Earnings Details
12/14/2017Q1 2018($0.02)($0.04)$0.65 million$0.46 millionViewN/AView Earnings Details
10/26/2017Q4 2017($0.03)($0.03)$0.75 million$0.52 millionViewN/AView Earnings Details
6/8/2017Q3 2017($0.02)($0.02)$1.00 million$0.34 millionViewListenView Earnings Details
3/2/2017Q2 2017($0.02)($0.01)$0.85 million$0.45 millionViewN/AView Earnings Details
12/14/2016Q1 2017($0.03)$0.53 millionViewN/AView Earnings Details
10/27/2016Q4 2016($0.03)($0.01)$0.80 million$0.52 millionViewN/AView Earnings Details
6/9/2016Q3 2016($0.03)($0.04)$0.40 millionViewN/AView Earnings Details
3/9/2016Q2 2016($0.03)($0.04)$0.23 million$0.18 millionViewN/AView Earnings Details
12/10/2015Q1 2016($0.05)($0.05)$0.30 million$0.19 millionViewN/AView Earnings Details
10/28/2015Q4 2015($0.04)($0.04)$0.30 million$0.23 millionViewN/AView Earnings Details
6/11/2015Q3 2015($0.04)($0.05)$0.35 million$0.11 millionViewN/AView Earnings Details
3/4/2015($0.04)($0.04)$0.20 million$0.27 millionViewN/AView Earnings Details
12/11/2014($0.06)($0.05)$0.30 million$0.12 millionViewN/AView Earnings Details
10/28/2014($0.07)($0.09)$0.36 million$0.13 millionViewN/AView Earnings Details
6/10/2014Q314($0.05)($0.07)$0.2580 million$0.2610 millionViewN/AView Earnings Details
3/13/2014Q2 2014($0.05)($0.12)$0.30 million$0.04 millionViewN/AView Earnings Details
12/12/2013Q1 14($0.06)($0.19)$0.25 million$0.12 millionViewN/AView Earnings Details
10/24/2013Q4 2013($0.05)($0.18)$0.19 millionViewN/AView Earnings Details
6/14/2013Q3 2013($0.16)($0.14)$0.40 million$0.26 millionViewN/AView Earnings Details
2/26/2013Q2 2013($0.20)($0.17)$0.30 million$0.26 millionViewN/AView Earnings Details
12/12/2012-0.25($0.25)$0.2570 million$0.2570 millionViewN/AView Earnings Details
10/30/2012Q4 2012($0.32)($1.42)ViewN/AView Earnings Details
6/13/2012Q3 2012($0.40)($0.32)ViewN/AView Earnings Details
3/16/2012Q2 2012($0.48)($0.41)ViewN/AView Earnings Details
12/15/2011Q1 2012($0.32)($0.46)ViewN/AView Earnings Details
10/31/2011Q4 2011($0.32)($0.40)ViewN/AView Earnings Details
6/13/2011Q3 2011($0.48)($0.39)ViewN/AView Earnings Details
3/17/2011Q2 2011($0.54)ViewN/AView Earnings Details
12/15/2010Q1 2011($0.46)ViewN/AView Earnings Details
10/28/2010Q4 2010($0.40)ViewN/AView Earnings Details
6/9/2010Q3 2010($0.37)ViewN/AView Earnings Details
3/11/2010Q2 2010($0.41)ViewN/AView Earnings Details
12/11/2009Q1 2010($0.41)ViewN/AView Earnings Details
10/13/2009Q4 2009($0.40)ViewN/AView Earnings Details
6/10/2009Q3 2009($0.40)ViewN/AView Earnings Details
3/12/2009Q2 2009($0.59)ViewN/AView Earnings Details
12/11/2008Q1 2009($0.40)ViewN/AView Earnings Details
10/14/2008Q4 2008($0.40)ViewN/AView Earnings Details
6/13/2008Q3 2008($0.72)ViewN/AView Earnings Details
3/17/2008Q2 2008($0.40)($0.48)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Pure Bioscience (OTCMKTS:PURE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pure Bioscience (OTCMKTS PURE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 10.56%
Institutional Ownership Percentage: 0.24%
Insider Trading History for Pure Bioscience (OTCMKTS:PURE)

Pure Bioscience (OTCMKTS PURE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2018Henry R LambertCEOSell41,500$0.93$38,595.00View SEC Filing  
4/12/2017Henry R. LambertCEOSell3,301$0.95$3,135.95View SEC Filing  
12/21/2016Tom Y. LeeDirectorSell14,885$0.95$14,140.75View SEC Filing  
8/1/2014William OtisDirectorBuy20,000$0.85$17,000.00View SEC Filing  
7/18/2014David M ThenoDirectorBuy30,000$0.85$25,500.00View SEC Filing  
7/2/2014David J PfanzelterDirectorBuy35,294$0.85$29,999.90View SEC Filing  
11/1/2013Henry R LambertCEOBuy40,000$0.75$30,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pure Bioscience (OTCMKTS PURE) News Headlines

Source:
DateHeadline
Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10thCoherus BioSciences to Report First Quarter 2018 Financial Results on May 10th
finance.yahoo.com - April 24 at 3:11 PM
ValuEngine Downgrades Pure Bioscience (PURE) to SellValuEngine Downgrades Pure Bioscience (PURE) to Sell
www.americanbankingnews.com - April 20 at 1:19 PM
Financial Contrast: Pure Bioscience (PURE) versus Orion Engineered Carbons (OEC)Financial Contrast: Pure Bioscience (PURE) versus Orion Engineered Carbons (OEC)
www.americanbankingnews.com - April 16 at 11:19 AM
Rounds Report: Nephros And Protalix Bulls Charged Ahead While Crispr Insiders Built SharesRounds Report: Nephros And Protalix Bulls Charged Ahead While Crispr Insiders Built Shares
seekingalpha.com - April 15 at 8:13 AM
Q3 2018 EPS Estimates for PURE Bioscience (PURE) Reduced by Zacks Investment ResearchQ3 2018 EPS Estimates for PURE Bioscience (PURE) Reduced by Zacks Investment Research
www.americanbankingnews.com - March 21 at 8:18 AM
FY2019 EPS Estimates for PURE Bioscience Decreased by Analyst (PURE)FY2019 EPS Estimates for PURE Bioscience Decreased by Analyst (PURE)
www.americanbankingnews.com - March 20 at 2:28 PM
Head to Head Survey: PURE Bioscience (PURE) & Its PeersHead to Head Survey: PURE Bioscience (PURE) & Its Peers
www.americanbankingnews.com - March 18 at 11:28 AM
Edited Transcript of PURE earnings conference call or presentation 14-Mar-18 8:30pm GMTEdited Transcript of PURE earnings conference call or presentation 14-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 5:43 AM
PURE Bioscience (PURE) Announces  Earnings ResultsPURE Bioscience (PURE) Announces Earnings Results
www.americanbankingnews.com - March 15 at 1:38 PM
PURE Bioscience Provides Update: Expanding Use of PURE Control® Antimicrobial in Produce Processing; Expanding Use of PURE® Hard Surface DisinfectantPURE Bioscience Provides Update: Expanding Use of PURE Control® Antimicrobial in Produce Processing; Expanding Use of PURE® Hard Surface Disinfectant
finance.yahoo.com - February 28 at 3:14 PM
PURE Bioscience to Present at the 30th Annual ROTH Capital Partners ConferencePURE Bioscience to Present at the 30th Annual ROTH Capital Partners Conference
finance.yahoo.com - February 28 at 5:21 AM
PURE Bioscience Receives Initial Orders from Leading Foodservice Distributor for PURE® Hard Surface Food Transport Sanitization SolutionPURE Bioscience Receives Initial Orders from Leading Foodservice Distributor for PURE® Hard Surface Food Transport Sanitization Solution
finance.yahoo.com - January 17 at 10:08 AM
Insider Selling: PURE Bioscience (PURE) CEO Sells 41,500 Shares of StockInsider Selling: PURE Bioscience (PURE) CEO Sells 41,500 Shares of Stock
www.americanbankingnews.com - January 12 at 7:26 PM
ValuEngine Upgrades PURE Bioscience (PURE) to "Hold"ValuEngine Upgrades PURE Bioscience (PURE) to "Hold"
www.americanbankingnews.com - December 31 at 1:32 PM
PURE Bioscience (PURE) Stock Rating Lowered by ValuEnginePURE Bioscience (PURE) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - December 25 at 5:53 PM
Contrasting Tronox (TROX) & PURE Bioscience (PURE)Contrasting Tronox (TROX) & PURE Bioscience (PURE)
www.americanbankingnews.com - December 20 at 9:28 PM
Head to Head Analysis: PURE Bioscience (PURE) versus Tronox (TROX)Head to Head Analysis: PURE Bioscience (PURE) versus Tronox (TROX)
www.americanbankingnews.com - December 20 at 7:10 PM
JSR Announces Acquisition of Crown Biosciences InternationalJSR Announces Acquisition of Crown Biosciences International
www.businesswire.com - December 20 at 4:40 PM
Tronox (TROX) and PURE Bioscience (PURE) Critical SurveyTronox (TROX) and PURE Bioscience (PURE) Critical Survey
www.americanbankingnews.com - December 20 at 9:32 AM
PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q1, 2018 By the Numbers : December 18, 2017PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q1, 2018 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 4:39 PM
Contrasting Tronox (TROX) and PURE Bioscience (PURE)Contrasting Tronox (TROX) and PURE Bioscience (PURE)
www.americanbankingnews.com - December 17 at 3:12 AM
Analyzing PURE Bioscience (PURE) & Tronox (TROX)Analyzing PURE Bioscience (PURE) & Tronox (TROX)
www.americanbankingnews.com - December 16 at 9:24 PM
Tronox (TROX) & PURE Bioscience (PURE) Critical AnalysisTronox (TROX) & PURE Bioscience (PURE) Critical Analysis
www.americanbankingnews.com - December 16 at 3:24 PM
BRIEF-Pure Bioscience Reports Q1 Loss Per Share $0.04BRIEF-Pure Bioscience Reports Q1 Loss Per Share $0.04
www.reuters.com - December 16 at 10:16 AM
Edited Transcript of PURE earnings conference call or presentation 14-Dec-17 9:30pm GMTEdited Transcript of PURE earnings conference call or presentation 14-Dec-17 9:30pm GMT
finance.yahoo.com - December 16 at 10:16 AM
Tronox (TROX) and PURE Bioscience (PURE) Head-To-Head ReviewTronox (TROX) and PURE Bioscience (PURE) Head-To-Head Review
www.americanbankingnews.com - December 16 at 1:30 AM
Tronox (TROX) versus PURE Bioscience (PURE) Financial AnalysisTronox (TROX) versus PURE Bioscience (PURE) Financial Analysis
www.americanbankingnews.com - December 15 at 9:32 PM
Tronox (TROX) vs. PURE Bioscience (PURE) Head to Head AnalysisTronox (TROX) vs. PURE Bioscience (PURE) Head to Head Analysis
www.americanbankingnews.com - December 15 at 8:45 AM
PURE Bioscience (PURE) Issues Quarterly  Earnings Results, Misses Expectations By $0.02 EPSPURE Bioscience (PURE) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - December 14 at 7:58 PM
PURE Bioscience Reports Fiscal 2018 Q1 Financial ResultsPURE Bioscience Reports Fiscal 2018 Q1 Financial Results
finance.yahoo.com - December 14 at 5:12 PM
Tronox (TROX) & PURE Bioscience (PURE) Head to Head ReviewTronox (TROX) & PURE Bioscience (PURE) Head to Head Review
www.americanbankingnews.com - December 11 at 11:26 AM
Reviewing PURE Bioscience (PURE) and Tronox (TROX)Reviewing PURE Bioscience (PURE) and Tronox (TROX)
www.americanbankingnews.com - December 8 at 9:52 AM
PURE Bioscience (PURE) Scheduled to Post Quarterly Earnings on ThursdayPURE Bioscience (PURE) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - December 7 at 1:26 AM
Head-To-Head Analysis: Tronox (TROX) & PURE Bioscience (PURE)Head-To-Head Analysis: Tronox (TROX) & PURE Bioscience (PURE)
www.americanbankingnews.com - December 7 at 1:24 AM
Head-To-Head Comparison: Tronox (TROX) & PURE Bioscience (PURE)Head-To-Head Comparison: Tronox (TROX) & PURE Bioscience (PURE)
www.americanbankingnews.com - December 6 at 11:24 AM
Comparing PURE Bioscience (PURE) and Tronox (TROX)Comparing PURE Bioscience (PURE) and Tronox (TROX)
www.americanbankingnews.com - December 6 at 9:30 AM
Reviewing PURE Bioscience (PURE) & Tronox (TROX)Reviewing PURE Bioscience (PURE) & Tronox (TROX)
www.americanbankingnews.com - December 6 at 3:44 AM
Tronox (TROX) vs. PURE Bioscience (PURE) Critical ReviewTronox (TROX) vs. PURE Bioscience (PURE) Critical Review
www.americanbankingnews.com - December 5 at 9:26 PM
Head to Head Comparison: PURE Bioscience (PURE) versus Tronox (TROX)Head to Head Comparison: PURE Bioscience (PURE) versus Tronox (TROX)
www.americanbankingnews.com - November 27 at 10:26 AM
PURE Bioscience (PURE) vs. Tronox (TROX) Head-To-Head SurveyPURE Bioscience (PURE) vs. Tronox (TROX) Head-To-Head Survey
www.americanbankingnews.com - November 26 at 5:50 PM
Isodiol International Inc. Signs Binding Agreement to Acquire 100% of C3 Global BiosciencesIsodiol International Inc. Signs Binding Agreement to Acquire 100% of C3 Global Biosciences
globenewswire.com - November 24 at 5:48 PM
Isodiol International Inc. Signs Definitive Agreement to Acquire Bradley’s Bioscience Inc., and Closes Strategic FinancingIsodiol International Inc. Signs Definitive Agreement to Acquire Bradley’s Bioscience Inc., and Closes Strategic Financing
globenewswire.com - November 23 at 7:53 AM
FY2019 EPS Estimates for PURE Bioscience (PURE) Boosted by Zacks Investment ResearchFY2019 EPS Estimates for PURE Bioscience (PURE) Boosted by Zacks Investment Research
www.americanbankingnews.com - November 18 at 10:56 AM
PURE Bioscience (PURE) Cut to "Sell" at ValuEnginePURE Bioscience (PURE) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - November 16 at 11:34 PM
PURE Bioscience to Present at the 10th Annual LD Micro ConferencePURE Bioscience to Present at the 10th Annual LD Micro Conference
finance.yahoo.com - November 15 at 7:44 AM
PURE Bioscience (PURE) Lowered to "Sell" at ValuEnginePURE Bioscience (PURE) Lowered to "Sell" at ValuEngine
www.americanbankingnews.com - November 10 at 10:34 PM
PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety ConsultantPURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
finance.yahoo.com - November 4 at 9:40 AM
PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q4, 2017 By the Numbers : October 30, 2017PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q4, 2017 By the Numbers : October 30, 2017
finance.yahoo.com - November 1 at 7:47 AM
Analyzing Tronox (TROX) and PURE Bioscience (PURE)Analyzing Tronox (TROX) and PURE Bioscience (PURE)
www.americanbankingnews.com - October 27 at 7:24 PM
PURE Bioscience Announces Partnership with iGPS LogisticsPURE Bioscience Announces Partnership with iGPS Logistics
finance.yahoo.com - October 27 at 12:15 PM

SEC Filings

Pure Bioscience (OTCMKTS:PURE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pure Bioscience (OTCMKTS:PURE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pure Bioscience (OTCMKTS PURE) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.